CETAT Committee

Click here to access the CETAT Committee area (must be logged in and a member of this committee).


DrIannitti120.jpg

CETAT Committee Chair

David A. Iannitti, MD, FACS

The Committee on Emerging Technologies and Therapeutic's (CETAT) task is to identify promising emerging technologies and therapeutics applicable to the treatment of pancreatic, liver, and biliary disease that are in the design or development stage. The committee will develop strategies to engage inventors and/or company representatives and serve as a liaison between them and other key members and committees of the AHPBA such as the research, program and development committees. The objective of the committee will be to provide an avenue through the AHPBA sponsored meetings, symposia and research opportunities that can help companies accelerate the introduction of new technology and therapeutics into the clinical arena.

David Iannitti, MD, FACS - Chair

Arthur James Moser, MD - Vice/Co-Chair

Anton J. Bilchik, MD, PhD, FACS

Kevin Charpentier, MD

Steven A. Curley, MD

Jeffrey A. Drebin, MD

Yuman Fong, MD

Arthur A. Fusco, MD

Christos A. Galanopoulos, MD, FACS

Mariano Eduardo Gimenez, MD

Niraj Gusani, MD

William G. Hawkins, MD

Michael L. Kendrick, MD

Elizabeth A. Pomfret, MD, PhD

Ponnandai S. Somasundar, MD

Steven M. Strasberg, MD

Kenneth K. Tanabe, MD

Selwyn M. Vickers, MD, FACS

Charles Edouard Zurstrassen, MD

William C. Chapman, MD Ex Officio

Kim O'Dell Ex-Officio